| 18 years and more
- | Country :
- France
- | organs :
- Prostate
- | Specialty :
- Immunothérapie - Vaccinothérapie
- Hormonothérapie
Extract
MK3475-641 - A Phase 3, Randomized, Double-blind Trial of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (KEYNOTE-641)